Blood cancers

Podcast: Where does carfilzomib fit in the R/R multiple myeloma setting?

The treatment landscape for relapsed, refractory multiple myeloma has been constantly evolving with new treatments and trials keeping everyone on their toes.

Following the Amgen Multiple Myeloma Webinar Series we speak to Dr Jesús San Miguel and Dr Paula Rodriguez from the University of Pamplona, Spain about where carfilzomib fits in the current treatment paradigm.

the limbic · Where does carfolzomib fit in the R/R myeloma setting?

Already a member?

Login to keep reading.

Email me a login link

© 2022 the limbic